Publication:
Thymic Function Impacts the Peripheral CD4/CD8 Ratio of HIV-Infected Subjects.

dc.contributor.authorRosado-Sánchez, I
dc.contributor.authorHerrero-Fernández, I
dc.contributor.authorGenebat, M
dc.contributor.authorRuiz-Mateos, E
dc.contributor.authorLeal, M
dc.contributor.authorPacheco, Yolanda M
dc.date.accessioned2023-01-25T09:42:39Z
dc.date.available2023-01-25T09:42:39Z
dc.date.issued2016-10-20
dc.description.abstract The persistence of an inverted CD4/CD8 ratio has been extensively associated with the increased morbimortality of chronic human immunodeficiency virus (HIV)-infected subjects. Thymic function is crucial for the maintenance of T cell homeostasis. We explored the impact of thymic function on the CD4/CD8 ratio of HIV-infected subjects.  In a cohort of 53 antiretroviral-naive HIV-infected subjects, the measure of thymic volume, as a representative marker for thymic function, was available at baseline and at 12, 24, and 48 weeks post antiretroviral treatment.  Baseline thymic volume was associated with the CD4/CD8 ratio ( Ρ: = 0.413, P = .002), being this association highly dependent on the CD4 T cell levels. In subjects who achieved undetectable viral load after treatment (n = 33), a higher baseline thymic volume was associated with a higher increase in CD4 T cell counts and a decreasing trend in CD8 T cell counts during follow-up. Moreover, the baseline thymic volume was independently associated with the normalization of the CD4/CD8 ratio after 96 weeks of treatment (odds ratio, 95% confidence interval: 1.95 (1.07-3.55); P = .03).  Our data indicate the relevance of the remaining thymic function before the start of treatment to the CD4/CD8 ratio of HIV- infected subjects and, hence, potentially, in their clinical progression.
dc.identifier.doi10.1093/cid/ciw711
dc.identifier.essn1537-6591
dc.identifier.pmid27986677
dc.identifier.unpaywallURLhttps://academic.oup.com/cid/article-pdf/64/2/152/13803513/ciw711.pdf
dc.identifier.urihttp://hdl.handle.net/10668/10690
dc.issue.number2
dc.journal.titleClinical infectious diseases : an official publication of the Infectious Diseases Society of America
dc.journal.titleabbreviationClin Infect Dis
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number152-158
dc.pubmedtypeJournal Article
dc.rights.accessRightsopen access
dc.subjectCD4/CD8 ratio
dc.subjectHIV
dc.subjectantiretroviral naive.
dc.subjectdelta-TRECs
dc.subjectthymic function
dc.subject.meshAdult
dc.subject.meshAntiretroviral Therapy, Highly Active
dc.subject.meshBiomarkers
dc.subject.meshCD4 Lymphocyte Count
dc.subject.meshCD4-CD8 Ratio
dc.subject.meshFemale
dc.subject.meshHIV Infections
dc.subject.meshHIV-1
dc.subject.meshHumans
dc.subject.meshImmunophenotyping
dc.subject.meshMale
dc.subject.meshOrgan Size
dc.subject.meshPhenotype
dc.subject.meshT-Lymphocyte Subsets
dc.subject.meshThymus Gland
dc.subject.meshTomography, X-Ray Computed
dc.subject.meshTreatment Outcome
dc.subject.meshViral Load
dc.titleThymic Function Impacts the Peripheral CD4/CD8 Ratio of HIV-Infected Subjects.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number64
dspace.entity.typePublication

Files